Introduction {#sec1}
============

Tissue inhibitor of metalloproteinases 3 (TIMP-3) is unique among the family of mammalian TIMPs in that it binds to the extracellular matrix (ECM), whereas the other TIMPs (TIMP-1, TIMP-2, and TIMP-4) diffuse freely in the extracellular environment ([@bib4; @bib5]). This ECM-binding ability is thought to position TIMP-3 as a major inhibitor of ECM turnover, and *Timp3*-null mice exhibit a range of phenotypes associated with increased ECM degradation. For example, the mice show increased collagen degradation in the lungs, leading to increased alveolar size, impaired lung function, and reduced life span ([@bib26]). Additional phenotypes associated with increased ECM degradation include elevated epithelial apoptosis upon mammary gland involution ([@bib12]), impaired bronchiole branching morphogenesis ([@bib15]), cardiac hypertrophy ([@bib13]), increased cardiac remodeling after myocardial infarction ([@bib40]), and accelerated spontaneous osteoarthritis ([@bib35]).

Although ECM binding is a distinguishing feature of TIMP-3, the molecular mechanism and functional consequences of ECM binding remain unknown. [@bib50] showed that TIMP-3 can be solubilized from uterine tissue by adding sulfated glycosaminoglycans such as heparin, heparan sulfate, and chondroitin sulfates. TIMP-3 has also been shown to bind to heparin in vitro, leading the authors to suggest that TIMP-3 binds to sulfated glycosaminoglycans (sGAGs) in the ECM. This was supported by [@bib27], who identified a highly basic region on the surface of TIMP-3 that, they postulated, interacts with negatively charged sulfated ECM components. By mutation of this basic region, they generated a soluble mutant of TIMP-3 that did not bind to the ECM. However, although it is generally accepted that TIMP-3 binds to sGAG in the ECM, it is not known to which specific sGAG TIMP-3 binds and whether specific proteoglycans carry the TIMP-3-binding sGAG.

TIMP-3 secreted from the cell can be cleared from the extracellular environment through cellular uptake and degradation mediated by the endocytic receptor low-density lipoprotein receptor-related protein 1 (LRP-1) ([@bib36; @bib43]). It is unclear what determines postsecretory trafficking of TIMP-3 to the ECM or to endocytosis and how this balance is regulated in health and disease. Although several factors regulate TIMP-3 transcription, posttranslational regulatory mechanisms appear to be central in determining TIMP-3 availability ([@bib43]). Reduced tissue levels of TIMP-3 are associated with several pathological conditions, such as osteoarthritis ([@bib31]), cancer ([@bib9]), and atherosclerosis ([@bib6]). Therefore, identification of the molecular determinants that regulate TIMP-3 trafficking in the extracellular environment is important to understand both physiological and pathological ECM degradation.

We set out to identify to which ECM glycosaminoglycans TIMP-3 binds and to determine their effects on TIMP-3 trafficking and affinity for target metalloproteinases.

Results {#sec2}
=======

TIMP-3 Binds to Heparan Sulfate and Chondroitin Sulfate E {#sec2.1}
---------------------------------------------------------

Using a solid-phase binding assay, we investigated TIMP-3 binding to several glycosaminoglycans. TIMP-3 bound strongly to highly sulfated heparin (12.5 kDa, K~D~ = 19 ± 4 nM) and to pentosan polysulfate (PPS, 4.7 kDa, K~D~ = 3 ± 0.4 nM), a highly sulfated polyxylan generated by chemical sulfation of cellulose ([Figure 1](#fig1){ref-type="fig"}). TIMP-3 had a comparable affinity for the natural matrix glycan heparan sulfate (HS, 22 kDa), with a K~D~ of 29 ± 18 nM. TIMP-3 also bound strongly to chondroitin sulfate E (CSE), a 4,6-*O*-disulfated glycan. TIMP-3 had a higher affinity for CSE from squid (50 kDa, K~D~ = 10 ± 1 nM) than for CSE from bonito (8.7 kDa, K~D~ = 39 ± 6 nM) ([Figure 1](#fig1){ref-type="fig"}). No binding to dermatan sulfate, aggrecan, hyaluronic acid, chondroitin-4-sulfate (C-4-S), or chondroitin-6-sulfate (C-6-S) was detected.

HS and CSE Block TIMP-3 Endocytosis by LRP-1 {#sec2.2}
--------------------------------------------

The effect of HS and CSE on TIMP-3 endocytosis by LRP-1 was investigated by adding recombinant TIMP-3 to HTB94 chondrosarcoma cells and following its disappearance from the medium by immunoblotting. TIMP-3 was taken up by the cells with a half-life of 5 hr, and this endocytosis was inhibited by an LRP ligand binding antagonist, receptor-associated protein (RAP) ([Figures 2](#fig2){ref-type="fig"}A and 2B). Endocytosis was also inhibited by preincubation of TIMP-3 with heparin, HS, or bonito CSE, whereas C-4-S had no effect ([Figures 2](#fig2){ref-type="fig"}A and 2B).

Little endogenous TIMP-3 was found in the culture medium of HTB94 cells, but TIMP-3 accumulated in the medium when cells were treated with CSE or HS ([Figure 2](#fig2){ref-type="fig"}C), indicating that they blocked endocytosis of endogenous TIMP-3. The amount of TIMP-3 detected was comparable with that seen in the presence of heparin and RAP. No TIMP-3 accumulated in the medium of cells treated with C-4-S.

Recombinant TIMP-3 bound to the ectodomain of LRP-1 with a K~D~ value of 28 ± 6 nM ([Figure 2](#fig2){ref-type="fig"}D). This binding was completely inhibited by preincubation of TIMP-3 with squid CSE and partially inhibited by bonito CSE, heparin, and HS.

HS and CSE Increase TIMP-3 Affinity for ADAMTS-5 {#sec2.3}
------------------------------------------------

We evaluated the effect of HS and CSE on TIMP-3 affinity for ADAMTS-5. In the absence of sGAGs, a K~i~ value of 1.36 ± 0.02 nM was calculated for TIMP-3 inhibition of ADAMTS-5 ([Figure 3](#fig3){ref-type="fig"}A), in agreement with previous reports ([@bib44; @bib45]). Addition of PPS (0.4 μg/ml, equivalent to 100 nM of 4.7 kDa polysaccharide or 2 μM disaccharide) improved the affinity between ADAMTS-5 and TIMP-3 so that even 0.5 nM ADAMTS-5 was fully inhibited by 0.5 nM TIMP-3 ([Figure 3](#fig3){ref-type="fig"}A), indicating a substantial affinity increase. We were unable to accurately determine the improved K~i~ because we could not measure the activity of lower enzyme concentrations, but, by fitting the data to the tight-binding equation ([@bib3]), we estimated that K~i~ is approximately 1 pM, a 1000-fold improvement.

K~i~ was similarly improved by addition of HS (8 μg/ml, equivalent to 1 μM of 22 kDa polysaccharide or 13 μM disaccharide) or heparin (1 μg/ml, equivalent to 100 nM of 12.5 kDa polysaccharide or 2 μM disaccharide) ([Figure 3](#fig3){ref-type="fig"}A) and also by CSE from bonito (1 μg/ml, equivalent to 100 nM of 8.7 kDa polysaccharide or 1.5 μM disaccharide) or squid (8 μg/ml, equivalent to 100 nM of 50 kDa polysaccharide or 8.3 μM disaccharide) ([Figure 3](#fig3){ref-type="fig"}B).

To compare their efficacies, increasing concentrations of HS and CSE were added to a fixed concentration of TIMP-3 and ADAMTS-5. Concentrations are expressed as molarity of disaccharide to allow comparison between HS and CSE of greatly differing lengths. At concentrations near a K~i~ of 1.36 nM, TIMP-3 only partially inhibited ADAMTS-5. Therefore, 0.5 nM TIMP-3 inhibited only 20% of the activity of 0.5 nM ADAMTS-5 ([Figure 3](#fig3){ref-type="fig"}A). At concentrations above 0.1 μM disaccharide, PPS improved the affinity between TIMP-3 and ADAMTS-5 so that 0.5 nM TIMP-3 completely inhibited 0.5 nM ADAMTS-5 ([Figure 3](#fig3){ref-type="fig"}C). The affinity was increased similarly by heparin and HS at disaccharide concentrations above 10 and 100 μM, respectively. CSE was similarly effective above 10 μM disaccharide, although bonito CSE (8.7 kDa) was less effective than squid CSE of 50, 200, or 800 kDa at lower concentrations.

HS and CSE Reduce the Dissociation Rate of the TIMP-3-ADAMTS-5 Complex {#sec2.4}
----------------------------------------------------------------------

Biolayer interferometry was used to further explore the mechanism by which sGAGs increase ADAMTS-5-TIMP-3 affinity. ADAMTS-5 bound to immobilized biotinylated TIMP-3 with a K~D~ of 72 ± 7 nM ([Figure 4](#fig4){ref-type="fig"}A). In accordance with previous experiments ([@bib42]), this is higher than the K~i~ calculated in solution, most likely because of the effects of TIMP-3 immobilization. The *k*~*off*~ value was determined as 23 ± 0.2 × 0^−3^ s^−1^ and the *k*~*on*~ rate as 1.41 × 10^4^ M^-1^.s^-1^.

Addition of sGAG markedly reduced the dissociation rate of the ADAMTS-5-TIMP-3 complex ([Figure 4](#fig4){ref-type="fig"}B) so that it was not possible to determine a value for *k*~*off*~ using this method. Squid CSE and PPS stabilized the complex to the extent that no dissociation was observed over 20 min, whereas minimal dissociation was observed with bonito CSE and HS.

sGAG had a lesser effect on association of TIMP-3 and ADAMTS-5, with the association rate increasing from 2.13 ± 0.02 M^-1^.s^-1^ in the absence of sGAG to 4.81 ± 0.03 M^-1^.s^-1^ in the presence of HS and 5.68 ± 0.04 M^-1^.s^-1^ in the presence of squid CSE.

Heparin of dp14 and Longer Increases Affinity {#sec2.5}
---------------------------------------------

We investigated the minimum chain length required for sGAG activity using heparin of differing sizes. TIMP-3 bound strongly to heparin with a degree of polymerization of 36 (dp36, 12.5 kDa) as well as to heparin of dp14 (5 kDa) and dp9 (3 kDa), with K~D~ values of 2 nM for all three heparin sizes ([Figure 5](#fig5){ref-type="fig"}A). TIMP-3 binding to dp5 heparin (1.7 kDa) was undetectable. Similarly, ADAMTS-5 bound strongly to heparin of dp36, dp14, and dp9, with K~D~ values of 10 nM for all three sizes ([Figure 5](#fig5){ref-type="fig"}B), and binding to dp5 heparin was undetectable.

Heparin of dp36 and dp14 effectively increased TIMP-3-ADAMTS-5 affinity, whereas heparins of dp9 and dp5 were ineffective at disaccharide concentrations of 1 μM ([Figure 5](#fig5){ref-type="fig"}C). Although dp9 heparin bound strongly to both proteins, it was unable to increase their affinities. This is most likely due to the lack of sufficient length to bridge the binding sites on the two proteins to form a high-affinity trimolecular complex.

The ability of heparin to block interaction between TIMP-3 and LRP-1 also depended on length. Heparins of dp36, dp14, and dp9 caused the accumulation of endogenous TIMP-3 in HTB94 cells, whereas dp5 heparin was ineffective (data not shown).

Heparin Sulfation Is Required for Affinity Increase and Endocytosis {#sec2.6}
-------------------------------------------------------------------

Using heparin of dp36, we examined the influence of sGAG sulfation. TIMP-3 bound to heparin with an estimated K~D~ of 2 nM. 2-*O*-desulfation and *N*-desulfation increased the K~D~ to 4 and 5 nM, respectively. 6-*O*-desulfation decreased affinity the most, with a K~D~ too high to be determined ([Figure 5](#fig5){ref-type="fig"}D). ADAMTS-5 bound to heparin with an estimated K~D~ of 9 nM. 2-*O*-desulfation had little effect on binding (K~D~ of 12 nM), whereas *N*-desulfation and 6-*O*-desulfation decreased affinity the most, and the K~D~ could not be determined ([Figure 5](#fig5){ref-type="fig"}E). Therefore, 6-*O*-desulfation had the greatest effect on binding to both proteins, and 2-*O*-desulfation had the least effect.

*N*-desulfation, 2-*O*-desulfation, and 6-*O*-desulfation all ablated the ability of heparin to increase the affinity between TIMP-3 and ADAMTS-5, with no improvement in affinity seen at up to 2 μM disaccharide. For 6-*O*-desulfated heparin, this correlated with a substantial reduction in binding to both proteins. 2-*O*-desulfated heparin had only a small reduction in binding to each protein (K~D~ reduced from 2 to 4 nM for TIMP-3 and from 9 to 12 nM for ADAMTS-5) but greatly affected the ability to increase the affinity between the two proteins ([Figure 5](#fig5){ref-type="fig"}F). This indicates that disulfation is critical for this trimolecular interaction.

TIMP-3 accumulated in the medium of cells treated with 2-*O*-desulfated and *N*-desulfated heparin but not in those treated with 6-*O*-desulfated heparin (data not shown). Therefore, the ability to block TIMP-3 endocytosis by LRP-1 correlated with the ability to bind to the inhibitor.

Effect of Heparin Ring Integrity on Affinity Increase {#sec2.7}
-----------------------------------------------------

Periodate-treated, glycol-split dp36 heparin bound to TIMP-3 and ADAMTS-5 as well as untreated heparin ([Figures 5](#fig5){ref-type="fig"}G and 5H) and was also effective at increasing ADAMTS-5-TIMP-3 affinity ([Figure 5](#fig5){ref-type="fig"}I) and blocking TIMP-3 endocytosis (data not shown).

TIMP-3 Colocalizes with Perlecan {#sec2.8}
--------------------------------

We stained for TIMP-3 in cartilage, a tissue with an ECM rich in multiple sGAGs. TIMP-3 colocalized with the HS-bearing proteoglycan perlecan in the pericellular matrix of femoral head cartilage ([Figure 6](#fig6){ref-type="fig"}A). This staining was absent in *Timp3*^−/−^ mice, confirming the specificity of the immunolocalization. Perlecan colocalization with TIMP-3 was also observed in the pericellular matrix of knee cartilage from adult mice ([Figure 6](#fig6){ref-type="fig"}B).

Cartilage Contains CSE {#sec2.9}
----------------------

Perlecan is well established to be an HS-containing proteoglycan. We investigated whether CS containing E-type disaccharide units is also present in cartilage by analyzing the disaccharide composition of cartilage CS. Both human and porcine adult cartilage contained the *N*-acetylgalactosamine 4,6-*O*-disulfate (ΔDi-diS~E~) unit characteristic of CSE ([Table 1](#tbl1){ref-type="table"}). As expected, given the abundance of aggrecan in cartilage, the majority of CS was either 4-sulfated (27% in human cartilage, 56% in porcine cartilage) or 6-sulfated (63% in human cartilage, 33% in porcine cartilage). The E-type disaccharide unit made up 3% of the total CS in human cartilage and 1% in porcine cartilage.

Discussion {#sec3}
==========

TIMP-3 has long been known to bind to the ECM, with this localization thought to position it optimally for inhibition of ECM-degrading metalloproteinases. In this study, we show that the matrix not only serves to maintain a reservoir of TIMP-3 but that it directly modulates TIMP-3 inhibitory activity and blocks its endocytic uptake and cellular degradation.

TIMP-3 is thought to bind to sGAG in the ECM ([@bib50]), but the specific TIMP-3-binding glycosaminoglycans and the proteoglycan(s) bearing these moieties have remained unidentified, largely because of the difficulties associated with expression, purification, and biochemical analysis of TIMP-3. Following our elucidation that the inhibitor is cleared rapidly from the medium of cultured cells by LRP-1-mediated endocytosis ([@bib43; @bib36]), we used a strategy of blocking endocytosis to purify sufficient recombinant TIMP-3 for such analyses and showed that HS and CS chains containing E-type disaccharide units are likely to be the physiological TIMP-3-binding sGAGs in the ECM. In cartilage, we found that TIMP-3 colocalizes with perlecan in the pericellular ECM, indicating that, in this tissue, perlecan is likely to be the proteoglycan responsible for TIMP-3 retention. Perlecan is primarily thought of as an HS proteoglycan ([@bib17]), but it can also bear CS ([@bib38]), dermatan sulfate (DS) ([@bib8]), or keratan sulfate ([@bib23]). Of particular interest, perlecan has been reported to carry CSE in bovine cartilage ([@bib25]). In this study, we found that the E-type CS disaccharide unit is also present in adult human and porcine cartilage. Perlecan may also mediate TIMP-3 binding to the ECM in other locations, such as in the basement membrane, and other HS- and CSE-bearing proteoglycans may bind TIMP-3 in other tissues. In cartilage, perlecan is exclusively localized in the pericellular matrix ([@bib19]), where it binds several growth factors and regulatory molecules. For example, FGF-2 bound to the HS chains of perlecan transduces mechanical stimuli to chondrocytes ([@bib47]). Perlecan expression increases in osteoarthritis (OA) cartilage ([@bib39]), but its sulfation status in disease is unknown.

TIMP-3 levels are primarily regulated posttranslationally, and the inhibitor is cleared from the extracellular environment by the endocytic receptor LRP-1 ([@bib36]). Heparin blocks TIMP-3 binding to LRP-1 and inhibits cellular endocytosis, suggesting that the LRP-1 binding site overlaps with the ECM-binding site, identified by [@bib27] as an extended patch of basic residues. Here we show that HS and CSE similarly block TIMP-3 binding to LRP-1 and inhibit its endocytosis. Extracellular trafficking of TIMP-3 is therefore regulated by the balance between matrix binding and endocytosis, and factors altering either matrix sulfation or the endocytic capacity of the cell will shift this balance. A number of other LRP-1 ligands also bind to sGAGs. For example, midkine, connective tissue growth factor, MMP-13, MMP-2, MMP-9, ADAMTS-4, and ADAMTS-5 are all LRP-1 ligands ([@bib28; @bib48; @bib49]) that have been shown to bind to heparin in vitro. This suggests that the model outlined here may not be unique to TIMP-3 and that extracellular levels of many bioactive molecules that bind to the ECM may be regulated by the interplay between matrix binding and LRP-1-mediated endocytosis. This positions ECM sulfation as a potential key regulator of the ECM proteome.

In addition to blocking LRP-1-mediated endocytosis, HS and CSE increased TIMP-3 affinity for ADAMTS-5. We estimate that affinity was increased by 1000-fold, indicating that the sGAGs are likely to have induced a conformational change in one or both of the proteins. PPS similarly increases TIMP-3 affinity for ADAMTS-4 ([@bib45]), so HS and CSE are likely to increase TIMP-3 affinity for other target metalloproteinases that bind to sGAG. Such enzymes are also likely to interact with the ECM, indicating that this mechanism selectively augments TIMP-3 inhibition of enzymes it is likely to encounter in the ECM environment. Target metalloproteinases that do not bind sGAG, including many MMPs, would escape this increase in affinity.

HS and CSE are the two most highly sulfated among the ECM sGAGs we tested, and sulfation is likely to be critical for their binding ability. Indeed, only disulfated CSE bound to TIMP-3, whereas monosulfated C-4-S and C-6-S did not. Although 2-*O*-desulfation did not greatly affect heparin binding to TIMP-3 or ADAMTS-5, it abolished the ability of heparin to increase the affinity between the two proteins. This indicates that the effects of the ECM on TIMP-3 may be altered under conditions that change sulfation. In cartilage, changes in sulfation have primarily focused on the most abundant proteoglycan, aggrecan. No data are available on changes in HS or CSE sulfation in cartilage with age or disease, but several potential mechanisms for eliciting such changes have been proposed. For example, expression of several HS-synthesizing enzymes is altered during inflammation ([@bib24]), and cartilage expression of the HS sulfatases Sulf-1 and Sulf-2 is increased with aging and in OA ([@bib32]), with *Sulf*-null mice developing OA more rapidly ([@bib33]). Studies on HS and CSE sulfation in cartilage are clearly warranted, given their important role in regulating the amount and activity of TIMP-3 as well as other regulatory proteins, such as FGF-2, CTGF, midkine, ADAMTS-4, and ADAMTS-5. Interestingly, TIMP-3 staining in the ECM of renal and pulmonary blood vessels increases with age ([@bib29]), with the authors postulating that the TIMP-3-binding capacity of the ECM may be increased by age-related changes in glycosylation.

CSE, containing the disulfated *N*-acetylgalactosamine 4,6-*O*-disulfate residue, was initially isolated from squid cartilage ([@bib22]) but has since been isolated from numerous mammalian sources. Its disulfated status confers CSE with a binding activity more similar to heparin than to monosulfated C-4-S or C-6-S. CSE has been shown to interact with a number of growth factors, including midkine ([@bib10]), pleiotrophin ([@bib10]), several fibroblast growth factors ([@bib2; @bib10]), heparin-binding epidermal growth factor ([@bib10]), brain-derived neurotrophic factor, and bone morphogenetic protein 4 ([@bib30]). CSE is particularly abundant in the brain ([@bib46]), where it is thought to play a role in brain development ([@bib34]), neurite outgrowth ([@bib37]), and neuronal plasticity ([@bib11]). It is intriguing to consider whether E-type CS disaccharide units may modulate TIMP-3 levels and activity in the brain. Our study implies that, rather than TIMP-3 exerting a protective effect on an inert extracellular matrix, the two have a symbiotic relationship, with changes in one bringing about changes in the other. This concept is likely to be of importance not only in cartilage but also in other physiological and pathological settings, such as wound healing, atherosclerosis, fibrosis, and cancer, with TIMP-3 and the sulfation pattern of glycosaminoglycans being important modulators of ECM turnover.

Significance {#sec4}
============

**Elucidation of the molecular mechanisms by which sulfated glycans affect protein activity is likely to be beneficial in understanding and modulating the behavior of many ECM-binding growth factors and biologically active proteins in a range of pathological conditions. In this study, we demonstrated that catabolism of the ECM is modulated by its own sulfation because this alters the extracellular levels and inhibitory activity of TIMP-3, a pivotal inhibitor of matrix-degrading metalloproteinase. HS and CSE selectively increase TIMP-3 levels in the matrix by inhibiting its binding to the endocytic receptor LRP-1 and subsequent degradation. These sulfated glycans also increase TIMP-3 affinity for a subset of ECM-degrading target metalloproteinases by reducing dissociation rate constants of the TIMP-3-metalloproteinase complexes. Our study suggests that synthetic glycan mimetics that similarly increase the TIMP-3 amount and activity in the extracellular environment would be potential lead compounds for the development of therapies to treat osteoarthritis and other diseases associated with increased ECM-degrading metalloproteinase activities.**

Experimental Procedures {#sec5}
=======================

Materials {#sec5.1}
---------

C-terminally FLAG-tagged human TIMP-3 ([@bib44]) and ADAMTS-5 lacking the C-terminal thrombospondin domain ([@bib14]) were prepared as before.

All glycan masses reported are average values. PPS was from Bene-PharmaChemie. Porcine mucosal HS from Iduron had an average mass of 22 kDa and contained highly sulfated 9 kDa and less sulfated 35 kDa species. C-4-S, C-6-S, porcine mucosal 12.5 kDa heparin, 5 kDa low molecular mass mucosal heparin, and 3 kDa heparin were purchased from Sigma-Aldrich. Heparin pentasaccharide (fondaparinux sodium) was from GlaxoSmithKline.

Desulfated heparins were prepared from 12.5 kDa porcine mucosal heparin. *N*-desulfated heparin was prepared as described by [@bib18]. 2-*O*-desulfated heparin was prepared by dissolving heparin in 0.2 M NaOH and then lyophilizing ([@bib20]). 6-*O*-desulfated heparin was prepared by hydrolysis with *N*-methyl-*N*-(trimethylsilyl)trifluoroacetamide ([@bib21]). Glycol-split heparin was prepared as described previously ([@bib7]).

CSE was purified from squid cartilage on diethylaminoethyl (DEAE)-Sephadex ([@bib16]). The 1.5 M NaCl eluate from this resin was further fractionated by gel filtration on Sepharose CL-4B equilibrated in 0.2 M NaCl. The eluate was pooled into three fractions, with average estimated molecular masses of 800 kDa (fraction 1), 200 kDa (fraction 2), and 50 kDa (fraction 3). Fractions were lyophilized, and the glycosaminoglycan content was quantified using the Elson-Morgan color reaction. Chondroitin sulfate E from bonito was a gift from Seikagaku. The disaccharide composition of the CSE preparations is shown in [Table S1](#mmc1){ref-type="supplementary-material"}.

M2 anti-FLAG antibody, Tween 20, DNase I, and proteinase K were from Sigma-Aldrich. Rabbit polyclonal anti-TIMP-3 and rat anti-perlecan were from Millipore. Anti-mouse horseradish peroxidase was from Dako. Anti-mouse and anti-rabbit alkaline phosphatases were from Promega. 3,3′,5,5′-Tetramethylbenzidine substrate was from KPL.

Glycosaminoglycan Binding Assay {#sec5.2}
-------------------------------

Glycosaminoglycans (10 μg/ml in PBS) were applied overnight at 25°C onto heparin binding plates (BD Life Sciences). Wells were washed in TIMP buffer (50 mM Tris-HCl \[pH 7.5\], 150 mM NaCl, 10 mM CaCl~2~, and 0.05% Brij-35) containing 0.1% (v/v) Tween 20 between each subsequent incubation. Wells were blocked with 0.2% (m/v) gelatin in TIMP buffer and then incubated with recombinant C-terminally FLAG-tagged TIMP-3 or ADAMTS-5 (0.08--100 nM in blocking solution, 3 hr, 37°C). Bound proteins were detected using M2 anti-FLAG antibody (3 hr, 37°C), followed by an anti-mouse antibody coupled to horseradish peroxidase (1 hr, 37°C). Hydrolysis of 3,3′,5,5′-tetramethylbenzidine substrate was measured at 450 nm using a FLUOstar Omega (BMG Labtech).

Analysis of TIMP-3 Endocytosis {#sec5.3}
------------------------------

HTB94 chondrosarcoma cells (6 × 10^5^ cells/well in Dulbecco\'s modified Eagle\'s medium \[DMEM\] with 10% fetal calf serum \[FCS\]) were washed twice in serum-free DMEM and warmed for 1 hr at 37°C in 1 ml of DMEM with 0.1% FCS. For RAP-treated wells, RAP (1 μM) was added to cells during this incubation period. Recombinant TIMP-3-FLAG (0.5 nM) was incubated (1 hr, 37°C) either alone or with 200 μg/ml of heparin, HS, C-4-S, or bonito CSE and then added to cells. Conditioned media were precipitated by addition of 5% (v/v) trichloroacetic acid (TCA) (4°C, 18 h). After centrifugation (13,000 rpm, 10 min, 4°C), pellets were suspended in reducing SDS sample buffer, electrophoresed on a 10% polyacrylamide gel, and immunoblotted onto polyvinylidene fluoride. After blocking in 5% (m/v) BSA in Tris-buffered saline, TIMP-3-FLAG was detected using M2 anti-FLAG antibody and an alkaline phosphatase-linked secondary antibody.

To measure the accumulation of endogenous TIMP-3 in the presence of sGAG, HTB94 chondrosarcoma cells (6 × 10^5^ cells/well in DMEM with 10% FCS) were washed twice in serum-free DMEM and incubated for 30 hr in 1 ml of serum-free DMEM containing RAP (0.5 and 0.75 μM), heparin, HS, C-4-S, or bonito CSE (100 and 200 μg/ml). Proteins were precipitated from media by addition of 5% (v/v) TCA, electrophoresed, and immunoblotted as described above. TIMP-3 was detected using polyclonal rabbit anti-TIMP-3 and an alkaline phosphatase-linked secondary antibody.

TIMP-3 Binding to LRP-1 {#sec5.4}
-----------------------

LRP-1 ectodomain (5 nM, BioMac) was applied (18 hr, 4°C) onto Costar 96-well immunosorbent assay plates in TIMP buffer without Brij-35. Wells were washed in TIMP buffer containing 0.1% (v/v) Tween 20 between each subsequent incubation. Wells were blocked (90 min, 37°C) in 3% (m/v) bovine serum albumin in TIMP buffer. TIMP-3 (1.5--80 nM) was preincubated (90 min, 37°C) with 200 μg/ml heparin, HS, bonito CSE, or squid CSE and then added to wells (37°C, 3 hr). Bound TIMP-3 was detected using M2 anti-FLAG antibody (2 hr, 37°C) and anti-mouse antibody coupled to horseradish peroxidase (1 hr, 37°C). Hydrolysis of 3,3′,5,5′-tetramethylbenzidine substrate was measured at 450 nm using a FLUOstar Omega (BMG Labtech).

Analysis of TIMP-3 Affinity for ADAMTS-5 {#sec5.5}
----------------------------------------

The affinity between TIMP-3 and ADAMTS-5 was measured using a steady-state enzyme kinetic analysis ([@bib3; @bib45]). TIMP-3 (0.5--2 nM) and ADAMTS-5 (0.5 nM) were incubated in TIMP buffer (1 hr, 37°C). Residual ADAMTS-5 activity was measured (18 hr, 37°C) using the fluorescent peptide substrate ortho-aminobenzoyl-Thr-Glu-Ser-Glu∼Ser-Arg-Gly-Ala-Ile-Tyr-(*N*-3-\[2,4-dinitrophenyl\]-[L]{.smallcaps}-2,3-diaminopropionyl)-Lys-Lys-NH~2~ (20 μM, Bachem). Endpoint fluorescence was measured using a Gemini microplate spectrofluorometer (Molecular Devices), and K~i~ was determined from steady-state velocities by fitting the data to the tight-binding equation using Prism software (GraphPad).

Biolayer Interferometry {#sec5.6}
-----------------------

TIMP-3 (200 nM) was biotinylated by incubation with EZ-Link succinimidyl 6-(biotinamido)hexanoate (10 μM, 30 min, 25°C, Thermo Fisher Scientific), and excess biotin was removed using a PD-10 desalting column (GE Healthcare). Biotinylated TIMP-3 was immobilized on streptavidin-coated biosensors (20 min, 25°C) using an Octet RED384 biolayer interferometer (Pall ForteBio). To determine the affinity between TIMP-3 and ADAMTS-5, TIMP-3-coated biosensors were incubated with ADAMTS-5 (50--500 nM in TIMP buffer), and association was observed for 10 min at 25°C. Tips were then incubated in TIMP buffer for a further 20 min at 25°C to observe dissociation of the complex. No binding of ADAMTS-5 to uncoated biosensors was observed. To determine the effect of sGAG on the affinity between TIMP-3 and ADAMTS-5, TIMP-3-coated biosensors were incubated with ADAMTS-5 (200 nM) and either PPS (100 nM), HS (100 μM), bonito CSE (10 μM), or squid CSE (10 μM) in TIMP buffer. Association was observed for 10 min at 25°C, after which tips were incubated in TIMP buffer for 20 min at 25°C to observe dissociation of the complex. Kinetic constants were calculated using a 1:1 binding model in ForteBio OctetRED evaluation data analysis software. K~D~ was calculated from equilibrium responses, and *k*~*off*~ was calculated by determining the first-order rate constant. Observed association rate constant (*k*~*obs*~) values were calculated by determining the second-order rate constant using GraphPad Prism, and *k*~*on*~ was calculated from linear regression of *k*~*obs*~ on ADAMTS-5 concentration.

Immunofluorescence {#sec5.7}
------------------

*Timp3*^−/−^ mice were provided by Professor Rama Khokha (Ontario Cancer Institute). Cartilage was avulsed from the femoral heads of 6-week-old wild-type and *Timp3*^−/−^ mice ([@bib26]) using forceps. The tissue was frozen in optimal cutting temperature (OCT) medium embedding matrix (CellPath) and cryosectioned (8 μm). Sections were air-dried (1 hr, ambient temperature) and fixed in ice-cold acetone (10 min, −20°C). Sections were blocked with 5% (v/v) goat serum and 3% (w/v) bovine serum albumin in PBS (1 hr, room temperature). TIMP-3 was detected using polyclonal rabbit anti-TIMP-3 (1 μg/ml) and anti-rabbit Alexa Fluor 488 (Molecular Probes). Perlecan was detected using rat anti-perlecan (1 μg/ml) and anti-rat Alexa Fluor 568 (Molecular Probes). Nuclei were stained with DAPI. Sections were viewed with a charge-coupled device camera-equipped microscope (Nikon TE-2000) with a ×40 objective lens.

Disaccharide Composition Analysis of Cartilage {#sec5.8}
----------------------------------------------

Human articular cartilage was obtained from knees of patients undergoing amputation because of soft tissue sarcoma or osteosarcoma. Patients provided informed consent following approval by the Riverside Ethics Committee. For the analysis shown, cartilage was pooled from three patients (two males, one female, 40--51 years of age). Porcine articular cartilage was dissected from metacarpophalangeal joints of commercially slaughtered pigs.

Lyophilized cartilage (30 mg dry weight) was suspended in 0.4 N KOH and stirred for 18 hr at room temperature. After neutralization with acetic acid, samples were digested sequentially with DNase I (10 hr, 37°C) and proteinase K (40 hr, 45°C). The enzymes were heat-inactivated (100°C, 5 min), the samples were centrifuged (13,000 rpm, 10 min, 4°C), and the supernatant was precipitated by addition of 3 volumes of cold ethanol containing 1.3% (m/v) potassium acetate (on ice, 30 min). Pellets were collected by centrifugation (13,000 rpm, 10 min, 4°C), dissolved in deionized water, and ethanol-precipitated a further two times before being dissolved in deionized water. The glycosaminoglycans were then applied to a DEAE-Sephacel resin (GE Healthcare) equilibrated in 20 mM Tris-HCl (pH 7.2). The column was washed in equilibration buffer containing 0.2 M NaCl and glycosaminoglycans eluted in equilibration buffer containing 2 M NaCl. The eluate was desalted by centrifugation on a Nanosep centrifugation filter unit (3 kDa molecular weight cutoff, Pall Life Sciences).

For CS analysis, chondroitinase ABC (5 milliunits, Seikagaku) was added to the filter cup in chondroitinase buffer (50 mM Tris-HCl \[pH 7.2\] and 1 mM CaCl~2~). After incubation for 1 hr at 37°C, unsaturated disaccharides were eluted by centrifugation (13,000 rpm, 20 min, 4°C) and analyzed by high-performance liquid chromatography (HPLC) on a Sensyu Pak Docosil column, with elution monitored by a fluorescence detector (model RF-10AxL, Shimadzu). HPLC was carried out as described by [@bib41], with a slightly modified elution condition. Briefly, the disaccharides were labeled after elution with 2-cyanoacetoamide (Wako Pure Chemicals Industries) ([@bib1]).
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![TIMP-3 Binds to Highly Sulfated Glycosaminoglycans\
Glycosaminoglycan-binding multiwell plates were coated with 10 μg/ml PPS, heparin, HS, DS, aggrecan, hyaluronic acid (HA), squid CSE, bonito CSE, C-4-S, or C-6-S. Wells were then incubated with TIMP-3-FLAG, and bound TIMP-3 was detected using M2 anti-FLAG primary antibody and a horseradish peroxidase-coupled secondary antibody.](gr1){#fig1}

![Sulfated Glycosaminoglycans Block LRP-1-Mediated Endocytosis of TIMP-3\
(A) HTB94 chondrosarcoma cells were incubated in serum-free DMEM with recombinant TIMP-3-FLAG (0.5 nM) either alone (control) or in the presence of RAP (1 μM), heparin (200 μg/ml), HS (200 μg/ml), C-4-S (200 μg/ml), or bonito CSE (200 μg/ml). TIMP-3 remaining in the medium was detected by immunoblotting using M2 anti-FLAG antibody.\
(B) TIMP-3 remaining in the medium of cells shown in (A) was quantified using Phoretix 1D software. Symbols indicate TIMP-3 alone (○) or with C-4-S (▼), HS (□), heparin (●), bonito CSE (♦), or RAP (▲).\
(C) HTB94 chondrosarcoma cells were incubated in serum-free DMEM containing RAP (0.5 and 0.75 μM), heparin (100 and 200 μg/ml), HS (100 and 200 μg/ml), C-4-S (100 and 200 μg/ml), or bonito CSE (100 and 200 μg/ml). Accumulation of endogenous TIMP-3 in the medium was detected by immunoblotting using a rabbit anti-TIMP-3 antibody.\
(D) LRP-1 (5 nM) was coated onto a microtiter plate and wells blocked with 3% (m/v) bovine serum albumin in TIMP buffer. Wells were then incubated with TIMP-3-FLAG (control) or with TIMP-3-FLAG preincubated for 1 hr at 37°C with heparin, HS, bonito CSE, or squid CSE (200 μg/ml). Bound TIMP-3-FLAG was detected using M2 anti-FLAG antibody.](gr2){#fig2}

![sGAGs Increase TIMP-3 Affinity for ADAMTS-5\
(A) ADAMTS-5 (0.5 nM) was incubated with TIMP-3 (0.5--10 nM, 1 hr, 37°C) in TIMP buffer alone (○) or with HS (□, 1 μM of 8 kDa polysaccharide and 13 μM disaccharide), heparin (●, 100 nM of 12.5 kDa polysaccharide and 2 μM disaccharide), or PPS (▵, 100 nM of 4.7 kDa polysaccharide and 0.8 μM disaccharide), and the residual activity against fluorescent peptide substrate was determined.\
(B) ADAMTS-5 (0.5 nM) was incubated with TIMP-3 (0.5--10 nM, 1 hr, 37°C) in TIMP buffer alone (○) or with bonito CSE (♦, 100 nM of 8.7 kDa polysaccharide and 1.5 μM disaccharide) or squid CSE (▿, 100 nM of 50 kDa polysaccharide and 8.3 μM disaccharide), and the residual activity against the fluorescent peptide substrate was determined.\
(C) TIMP-3 (0.5 nM) was incubated with ADAMTS-5 (0.5 nM) and various concentrations of HS (10^−8^--10^−4^ M disaccharide), heparin (10^−8^--10^−5^ M disaccharide), or PPS (10^−9^--10^−4^ M disaccharide) (1 hr, 37°C). The residual activity against the fluorescent peptide substrate was determined.\
(D) TIMP-3 (0.5 nM) was incubated with ADAMTS-5 (0.5 nM) and various concentrations of bonito CSE (10^−11^--10^−5^ M disaccharide), squid CSE fraction 1 (10^−8^--10^−5^ M disaccharide), squid CSE fraction 2 (10^−12^--10^−5^ M disaccharide), or squid CSE fraction 3 (10^−12^--10^−5^ M disaccharide) (1 hr, 37°C). The residual activity against the fluorescent peptide substrate was determined.](gr3){#fig3}

![Biolayer Interferometry Analysis Showing that sGAGs Reduce Dissociation of the TIMP-3-ADAMTS-5 Complex\
(A) Streptavidin tips were coated with biotinylated TIMP-3, and binding of ADAMTS-5 (20--500 nM) was analyzed by biolayer interferometry.\
(B) Streptavidin tips coated with biotinylated TIMP-3 were incubated with ADAMTS-5 (200 nM) and TIMP buffer (no GAG), HS (100 μM), bonito CSE (10 μM), PPS (100 nM), or squid CSE (10 μM) in TIMP buffer. Binding was analyzed by biolayer interferometry.](gr4){#fig4}

![Size and Sulfation Affect the Heparin-Mediated Increase in TIMP-3 Affinity for ADAMTS-5\
(A and B) Heparin (60 μM disaccharide) of dp36 (12.5 kDa), dp14 (5 kDa), dp9 (3 kDa), or dp5 (1.7 kDa) was immobilized on glycosaminoglycan-binding multiwell plates. The wells were then incubated with FLAG-tagged TIMP-3 (0.08--10 nM) (A) or FLAG-tagged ADAMTS-5 (0.3--20 nM) (B). Bound protein was detected using M2 anti-FLAG primary antibody and a horseradish peroxidase-coupled secondary antibody.\
(C) TIMP-3 (0.5 nM) and ADAMTS-5 (0.5 nM) were incubated (1 hr, 37°C) with various concentrations (1--2000 nM disaccharide) of heparin with dp36, dp14, dp9, or dp5. The residual activity against the fluorescent peptide substrate was determined.\
(D and E) Heparin (60 μM disaccharide) of dp36 (12.5 kDa) either normally sulfated (untreated), *N*-desulfated (*N*-deS), 6-*O*-desulfated (6-*O*-deS), or 2-*O*-desulfated (2-*O*-deS) was immobilized on glycosaminoglycan-binding multiwell plates. The wells were then incubated with FLAG-tagged TIMP-3 (0.08--10 nM) (D) or FLAG-tagged ADAMTS-5 (0.16--20 nM) (E). Bound protein was detected using M2 anti-FLAG primary antibody and a horseradish peroxidase-coupled secondary antibody.\
(F) TIMP-3 (0.5 nM) and ADAMTS-5 (0.5 nM) were incubated (1 hr, 37°C) with various concentrations (10--2000 nM disaccharide) of dp36 (12.5 kDa) heparin, either normally sulfated (untreated), *N*-desulfated, 6-*O*-desulfated, or 2-*O*-desulfated The residual activity against the fluorescent peptide substrate was determined.\
(G and H) Heparin of dp36 (untreated) or glycol-split dp36 heparin (60 μM disaccharide) were immobilized on glycosaminoglycan-binding multiwell plates, and the wells were then incubated with FLAG-tagged TIMP-3 (0.08--10 nM) (G) or FLAG-tagged ADAMTS-5 (0.16--20 nM) (H). Bound protein was detected using M2 anti-FLAG primary antibody and a horseradish peroxidase-coupled secondary antibody.\
(I) TIMP-3 (0.5 nM) and ADAMTS-5 (0.5 nM) were incubated (1 hr, 37°C) with various concentrations (10--2000 nM disaccharide) of dp36 heparin (untreated) or glycol-split dp36 heparin. The residual activity against the fluorescent peptide substrate was determined.](gr5){#fig5}

![TIMP-3 Colocalizes with Perlecan in the Pericellular Matrix of Cartilage\
(A) Hip cartilage from *Timp3*^+/+^ and *Timp3*^−/−^ mice were cryosectioned (8 μm). Sections were air-dried, fixed in ice-cold acetone, and blocked with 5% (v/v) goat serum and 3% (w/v) bovine serum albumin in PBS. TIMP-3 was detected using rabbit anti-TIMP-3 and anti-rabbit Alexa Fluor 468. Perlecan was detected using rat anti-perlecan and anti-rat Alexa Fluor 568. Nuclei were stained with DAPI. Scale bar, 23 μm.\
(B) Knee cartilage from wild-type mice was sectioned and stained as in (A).](gr6){#fig6}

###### 

Chondroitin Sulfate Disaccharide Composition of Human and Porcine Cartilage

  ΔDiS         Human Cartilage   Porcine Cartilage           
  ------------ ----------------- ------------------- ------- ----
  ΔDi-0S       0.006             1                   0.029   4
  ΔDi-4S       0.188             27                  0.424   56
  ΔDi-6S       0.436             63                  0.246   33
  ΔDi-diS~E~   0.019             3                   0.009   1
  ΔDi-diS~D~   0.047             7                   0.043   6

Sulfated glycosaminoglycans were isolated from human or porcine articular cartilage, fractionated by ion exchange chromatography, and digested with chondroitinase ABC. The resulting unsaturated disaccharides were analyzed by HLPC to determine the relative abundance of the various sulfated species.
